共 50 条
- [2] Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
- [4] Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model [J]. FRONTIERS IN ONCOLOGY, 2021, 11
- [6] ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma [J]. MOLECULAR THERAPY-ONCOLYTICS, 2022, 27 : 48 - 60
- [7] Comprehensive analysis of scRNA-seq and bulk RNA-seq reveal the characteristics of disulfidptosis and a prognostic signature in BLCA [J]. AGING-US, 2024, 16 (06): : 5751 - 5771
- [10] Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13823 - 13839